Cargando…
Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence
Autores principales: | Alsultan, Abdullah Saleh, Hakeam, Hakeam Abdulaziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074306/ https://www.ncbi.nlm.nih.gov/pubmed/29848943 http://dx.doi.org/10.5144/0256-4947.2018.233 |
Ejemplares similares
-
Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin
por: Hakeam, Hakeam, et al.
Publicado: (2019) -
Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report
por: Alsemari, Muhannad A., et al.
Publicado: (2020) -
Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study
por: Hakeam, Hakeam A., et al.
Publicado: (2020) -
Issues with generic drugs in Saudi Arabia
por: Asiri, Yousef Abdu, et al.
Publicado: (2006) -
Public knowledge, perception, and experience with generic medications in Saudi Arabia
por: Almohammed, Omar A., et al.
Publicado: (2020)